首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9054篇
  免费   866篇
  国内免费   37篇
耳鼻咽喉   114篇
儿科学   304篇
妇产科学   217篇
基础医学   1402篇
口腔科学   244篇
临床医学   754篇
内科学   2014篇
皮肤病学   243篇
神经病学   949篇
特种医学   295篇
外国民族医学   1篇
外科学   1300篇
综合类   43篇
一般理论   1篇
预防医学   690篇
眼科学   131篇
药学   612篇
中国医学   18篇
肿瘤学   625篇
  2023年   43篇
  2022年   52篇
  2021年   217篇
  2020年   154篇
  2019年   243篇
  2018年   306篇
  2017年   211篇
  2016年   233篇
  2015年   244篇
  2014年   299篇
  2013年   415篇
  2012年   536篇
  2011年   537篇
  2010年   332篇
  2009年   258篇
  2008年   425篇
  2007年   427篇
  2006年   452篇
  2005年   408篇
  2004年   374篇
  2003年   308篇
  2002年   323篇
  2001年   313篇
  2000年   297篇
  1999年   246篇
  1998年   82篇
  1997年   80篇
  1996年   73篇
  1995年   92篇
  1994年   68篇
  1993年   48篇
  1992年   204篇
  1991年   176篇
  1990年   162篇
  1989年   163篇
  1988年   146篇
  1987年   112篇
  1986年   107篇
  1985年   103篇
  1984年   93篇
  1983年   59篇
  1982年   40篇
  1981年   29篇
  1980年   32篇
  1979年   60篇
  1978年   32篇
  1976年   28篇
  1974年   40篇
  1973年   33篇
  1971年   31篇
排序方式: 共有9957条查询结果,搜索用时 156 毫秒
1.
The coronavirus disease 2019, which is caused by severe acute respiratory syndrome coronavirus 2, was first identified in December 2019 in Wuhan, China, and has since spread rapidly, evolving into a full-blown pandemic. We would like to report our experience after 1 year of this pandemic in the surgical service of a district hospital in Spain. There have been many changes (including new protocols) that our service and the hospital have undergone, to adapt to the new situation. We believe that this experience can be useful for other professionals who have lived and are living a similar situation.  相似文献   
2.
Cheryl L. Rock PhD  RD  Cynthia A. Thomson PhD  RD  Kristen R. Sullivan MS  MPH  Carol L. Howe MD  MLS  Lawrence H. Kushi ScD  Bette J. Caan DrPH  Marian L. Neuhouser PhD  RD  Elisa V. Bandera MD  PhD  Ying Wang PhD  Kimberly Robien PhD  RD  Karen M. Basen-Engquist PhD  MPH  Justin C. Brown PhD  Kerry S. Courneya PhD  Tracy E. Crane PhD  RDN  David O. Garcia PhD  FACSM  Barbara L. Grant MS  RDN  CSO  FAND  Kathryn K. Hamilton MA  RDN  CSO  CDN  FAND  Sheri J. Hartman PhD  Stacey A. Kenfield ScD  Maria Elena Martinez PhD  Jeffrey A. Meyerhardt MD  MPH  Larissa Nekhlyudov MD  MPH  Linda Overholser MD  Alpa V. Patel PhD  Bernardine M. Pinto PhD  Mary E. Platek PhD  RD  CDN  Erika Rees-Punia PhD  MPH  Colleen K. Spees PhD  MEd  RD  LD  FAND  Susan M. Gapstur PhD  Marjorie L. McCullough ScD  RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis.  相似文献   
3.
4.
5.

Context

Demoralization is a state of existential distress in patients with advanced illness, typically with coping difficulties, feelings of loss of sense, and purpose in life and despair, among other things. The New Demoralization Scale (DS-II) is an evaluation tool for this syndrome, which has recently been reformulated on a shorter scale.

Objectives

The objective of this study was to obtain a Spanish version of the DS-II and to assess its psychometric properties in advanced cancer patients in Spain and a number of Latin American countries.

Methods

Following a translation–back translation process, a validation study and a confirmatory analysis using structural equation models with their corresponding latent constructs were undertaken. Patients completed the DS-II in Spanish (DS-II (es)), the Hospital Anxiety and Depression Scale, and the Edmonton Symptom Assessment System–revised. Reliability was studied according to internal consistency; construct validity and concurrent validity with the Hospital Anxiety and Depression Scale and the Edmonton Symptom Assessment System–revised; discriminant validity using the Karnofsky Performance Status scale; and feasibility, with response ratio and required time. Cutoff points were established, and sensitivity and specificity were studied.

Results

The DS-II (es) was obtained. One hundred fifty patients completed the validation study. The confirmatory analysis showed coherence, and all items correlated positively with their subscales and with the overall scale. Cronbach's alpha for the DS-II (es) was 0.88, for the sense and purpose subscale 0.83, and for the coping ability 0.79. Demoralization correlated significantly with emotional distress (rho = 0.73, P < 0.001). The tool distinguished between patients with diverse functional levels (rho = ?0.319, P = 0.001). Cutoff points at 10 and 20 out of 32 were established. The scale showed high sensitivity (81.97%) and specificity (80.90%). The prevalence of demoralization was 33% in our sample.

Conclusion

The Spanish version of the new Kissane DS-II demoralization scale has shown to be valid, reliable, and feasible with adequate psychometric properties.  相似文献   
6.
Pediatric Surgery International - Repeated pediatric assault should be a never event. The purpose of this study was to evaluate the readmission and reinjury patterns in pediatric victims of assault...  相似文献   
7.
8.
Objective

To evaluate the relationship between compliance check violations, and characteristics of the tobacco retailer and neighborhood social vulnerability in Oklahoma.

Design

This cross-sectional study utilized the US Food and Drug Administration (FDA) Compliance Check Inspections of Tobacco Product Retailers database for 2015–2019. These data were combined with Neighborhood social vulnerability variables using the Centers for Disease Control and Prevention (CDC) Social Vulnerability Index.

Setting

The setting of this study is the state of Oklahoma, USA.

Outcome measures

The outcome variable for this analysis was whether a sale was made to the youth during the compliance check (e.g., violation; yes/no) regardless of the outcome of the violation, and number of violations per a retailer.

Results

We observed a strong association between having a violation and retailer store type, after controlling for socioeconomic vulnerability and percentage of mobile homes. The proportion of a tobacco retailer’s violations also varied by store type.

Conclusions

More targeted enforcements and retailer education by store type may be necessary to increase compliance.

  相似文献   
9.
10.
Multiple sclerosis(MS)is an inflammatory demyelinating disease of the central nervous system.The disability caused by inflammatory demyelination clinically dominates the early stages of relapsing-remitting MS and is reversible.Once there is considerable loss of axons,MS patients enter a secondary progressive stage.Disease-modifying drugs currently in use for MS suppress the immune system and reduce relapse rates but are not effective in the progressive stage.Various animal models of MS(mostly mouse and rat)have been established and proved useful in studying the disease process and response to therapy.The experimental autoimmune encephalomyelitis animal studies reviewed here showed that a chronic progressive disease can be induced by immunization with appropriate amounts of myelin oligodendrocyte glycoprotein together with mycobacterium tuberculosis and pertussis toxin in Freund's adjuvant.The clinical manifestations of autoimmune encephalomyelitis disease were prevented or reduced by treatment with certain pharmacological agents given prior to,at,or after peak disease,and the agents had protective effects as shown by inhibiting demyelination and damage to neurons,axons and oligodendrocytes.In the cuprizone-induced toxicity animal studies,the pharmacological agents tested were able to promote remyelination and increase the number of oligodendrocytes when administered therapeutically or prophylactically.A monoclonal IgM antibody protected axons in the spinal cord and preserved motor function in animals inoculated with Theiler's murine encephalomyelitis virus.In all these studies the pharmacological agents were administered singly.A combination therapy may be more effective,especially using agents that target neuroinflammation and neurodegeneration,as they may exert synergistic actions.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号